IL122774A0 - Neurturin and related growth factors - Google Patents

Neurturin and related growth factors

Info

Publication number
IL122774A0
IL122774A0 IL12277496A IL12277496A IL122774A0 IL 122774 A0 IL122774 A0 IL 122774A0 IL 12277496 A IL12277496 A IL 12277496A IL 12277496 A IL12277496 A IL 12277496A IL 122774 A0 IL122774 A0 IL 122774A0
Authority
IL
Israel
Prior art keywords
neurturin
methods
growth factors
vectors
human
Prior art date
Application number
IL12277496A
Other languages
English (en)
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Publication of IL122774A0 publication Critical patent/IL122774A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL12277496A 1995-08-28 1996-08-27 Neurturin and related growth factors IL122774A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/519,777 US5739307A (en) 1995-08-28 1995-08-28 Polynucleotide encoding neurturin neurotrophic factor
PCT/US1996/014065 WO1997008196A1 (en) 1995-08-28 1996-08-27 Neurturin and related growth factors

Publications (1)

Publication Number Publication Date
IL122774A0 true IL122774A0 (en) 1998-08-16

Family

ID=24069730

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12277496A IL122774A0 (en) 1995-08-28 1996-08-27 Neurturin and related growth factors

Country Status (12)

Country Link
US (6) US5739307A (ja)
EP (1) EP0787142B1 (ja)
JP (1) JP4222629B2 (ja)
AT (1) ATE315578T1 (ja)
AU (1) AU714107B2 (ja)
CA (1) CA2194172C (ja)
DE (1) DE69635738T2 (ja)
DK (1) DK0787142T3 (ja)
IL (1) IL122774A0 (ja)
MX (1) MX9800277A (ja)
NZ (3) NZ318939A (ja)
WO (1) WO1997008196A1 (ja)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743628B1 (en) * 1995-08-28 2004-06-01 Washington University Method of cell culture using neurturin
US6184200B1 (en) 1995-09-28 2001-02-06 Amgen Inc. Truncated glial cell line-derived neurotrophic factor
US6222022B1 (en) 1996-03-14 2001-04-24 Washington University Persephin and related growth factors
DE69732350T2 (de) 1996-03-14 2005-12-22 Washington University Persephin und verwandte wachstumsfaktoren
US7015316B1 (en) * 1996-03-14 2006-03-21 Washington University Polynucleotides encoding human persephin and related growth factors
BR9713055A (pt) 1996-11-15 2000-04-04 Genentech Inc Processo para isolar uma neurotrofina humana recombinante, composição de neurotrofina e processo para purificar uma neurotrofina
NZ501423A (en) * 1997-04-17 2002-02-01 Univ Washington Receptors for TGF-beta-related neurotrophic factors and use for treating disease
US7723473B2 (en) * 1997-06-19 2010-05-25 St. Louis University Peptide antagonists of TGF-beta family members and therapeutic uses thereof
US6043221A (en) * 1997-07-30 2000-03-28 Amgen Inc. Method for preventing and treating hearing loss using a neuturin protein product
SI1005358T1 (en) * 1997-07-30 2003-06-30 Amgen Inc. Use of a neurturin protein product for preventing and treating hearing loss
US6593133B1 (en) 1998-07-06 2003-07-15 Nsgene A/S Neurotrophic factors
KR100773776B1 (ko) * 1998-07-14 2007-11-12 얀센 파마슈티카 엔.브이. 신경친화성 성장 인자
US7067473B1 (en) * 1998-07-14 2006-06-27 Janssen Pharmaceutica N.V. Neurotrophic growth factor
US6268352B1 (en) * 1998-09-02 2001-07-31 The Regents Of The University Of California Promoters of neural regeneration
US6284540B1 (en) * 1998-09-29 2001-09-04 Washington University Artemin, a novel neurotrophic factor
ATE406907T1 (de) * 1998-10-28 2008-09-15 Cornell Res Foundation Inc Methoden zur regulierung der angiogenese und vaskuläre integrität mittels trk rezeptor liganden bdnf, nt-3 und nt-4
ES2246234T3 (es) 1999-05-04 2006-02-16 Strakan International Limited Glicosidos de androgenos y actividad androgenica de los mismos.
EP1179067B1 (en) * 1999-05-17 2006-12-13 BIOPHARM Gesellschaft zur biotechnologischen Entwicklung und zum Vertrieb von Pharmaka mbH Neuroprotective properties of gdf-15, a member of the tgf-beta superfamily
DE60045045D1 (de) * 1999-11-05 2010-11-11 Hexima Ltd Nukleinsäuremoleküle zur kodierung cyclisierbare aminosäuresequenzen
US6866851B1 (en) 1999-12-28 2005-03-15 Washington University GFRα1-RET specific agonists and methods therefor
GB0024550D0 (ja) 2000-10-06 2000-11-22 Oxford Biomedica Ltd
US7442370B2 (en) 2001-02-01 2008-10-28 Biogen Idec Ma Inc. Polymer conjugates of mutated neublastin
US7276580B2 (en) 2001-03-12 2007-10-02 Biogen Idec Ma Inc. Neurotrophic factors
AU2002250203B2 (en) 2001-03-28 2006-08-10 Biogen Ma Inc. Use of neublastin polypeptides for treating neuropathic pain
US7658926B2 (en) * 2001-09-14 2010-02-09 Opexa Pharmaceuticals, Inc. Autologous T-cell vaccines materials and methods
US20050222070A1 (en) * 2002-05-29 2005-10-06 Develogen Aktiengesellschaft Fuer Entwicklungsbiologische Forschung Pancreas-specific proteins
AU2003238178A1 (en) 2002-05-29 2003-12-12 Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung Pancreas-specific proteins
CN100567987C (zh) * 2002-08-08 2009-12-09 贝勒医学院 T细胞疫苗及其制备方法
EP1897552B1 (en) 2003-04-18 2009-06-17 Biogen Idec MA Inc. Polymer-conjugated glycosylated neublastin
US20040229269A1 (en) * 2003-05-15 2004-11-18 Ghazala Hashmi Hybridization-mediated analysis of polymorphisms
ATE478092T1 (de) 2003-06-10 2010-09-15 Nsgene As Verbesserte sekretion von neublastin
WO2005026382A1 (en) * 2003-09-12 2005-03-24 Stemcell Technologies Inc. Neural colony forming assay
US7598059B2 (en) 2003-10-02 2009-10-06 Biogen Idec Ma Inc. Neublastin expression constructs
RU2006117304A (ru) 2003-10-20 2007-12-10 Нсджин А/С (Dk) Генная терапия болезни паркинсона iv vivo
EP1694354B1 (en) 2003-11-27 2009-07-01 DeveloGen Aktiengesellschaft Method for preventing and treating diabetes using neurturin
AU2005277227B2 (en) 2004-08-19 2011-10-06 Biogen Ma Inc. Refolding transforming growth factor beta family proteins
MX2007002029A (es) 2004-08-19 2007-03-28 Biogen Idec Inc Variantes de neublastina.
TWI501774B (zh) 2006-02-27 2015-10-01 Biogen Idec Inc 神經性病症之治療
DK2016414T3 (en) * 2006-05-05 2015-12-07 Opexa Therapeutics T-cell vaccine
EP1872790A1 (en) 2006-06-26 2008-01-02 DeveloGen Aktiengesellschaft New formulation for increasing bioavailability of neurturin
CA2685686A1 (en) 2007-05-01 2008-11-13 Biogen Idec Ma Inc. Neublastin polypeptides for use increasing vascularization in a tissue
US8946201B2 (en) 2007-08-27 2015-02-03 Saint Louis University Methods for inhibiting TGF-β
EA201070484A1 (ru) 2007-11-05 2011-04-29 Девелоген Акциенгезельшафт Новые конъюгаты нейртурина для фармацевтического применения
CN102159219B (zh) 2008-09-16 2015-06-24 圣路易斯大学 提高转化生长因子-β信号发送的方法
US9127083B2 (en) 2009-10-30 2015-09-08 Ntf Therapeutics, Inc. Neurturin molecules
US8445432B2 (en) 2009-10-30 2013-05-21 Ntf Therapeutics Inc Neurturin molecules
JP2013509422A (ja) * 2009-10-30 2013-03-14 シーエヌエス セラピューティクス，インク． 改良されたニュールツリン分子
US8564522B2 (en) * 2010-03-31 2013-10-22 Apple Inc. Reduced-power communications within an electronic display
EP2394665A1 (en) * 2010-06-14 2011-12-14 F. Hoffmann-La Roche AG Cell-penetrating peptides and uses therof
WO2011157713A2 (en) 2010-06-14 2011-12-22 F. Hoffmann-La Roche Ag Cell-penetrating peptides and uses therof
US9869272B1 (en) 2011-04-20 2018-01-16 Martin A. Stuart Performance of a transcritical or supercritical CO2 Rankin cycle engine
EP2594295A1 (en) 2011-11-16 2013-05-22 Servicio Andaluz De Salud Nerve implants based on a compacted biomaterial containing cells
JP2019502674A (ja) * 2015-08-25 2019-01-31 ヒスタイド アクツィエンゲゼルシャフト 組織形成誘導用化合物及びその使用
KR20180043317A (ko) 2015-08-25 2018-04-27 히스티드 아게 조직 형성 유도용 화합물 및 그것의 용도
EA038283B1 (ru) * 2016-04-13 2021-08-04 Юниверситейт Маастрихт Способ лечения или предупреждения остеоартрита

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011914A (en) * 1989-01-05 1991-04-30 Collins Franklin D Purified ciliary neurotrophic factor
US5141856A (en) * 1989-01-05 1992-08-25 Synergen, Inc. Expression of purified ciliary neurotrophic factor
US5260417A (en) * 1989-04-03 1993-11-09 Genetics Institute, Inc. Megakaryocyte growth promoting activity protein
US5235043A (en) * 1990-04-06 1993-08-10 Synergen, Inc. Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins
EP0592675A1 (en) 1991-06-29 1994-04-20 Kao Corporation Method of forming fixed images
HU220795B1 (hu) * 1991-09-20 2002-05-28 Amgen Inc. Gliasejtvonal-eredetű neurotróf faktorfehérjék, továbbá berendezések és gyógyászati készítmények idegsejtkárosodás megelőzésére és kezelésére
EP0721464A4 (en) * 1993-09-01 1998-12-30 Start Technology Partnership NEURON REGULATOR FACTOR FOR PROMOTING NEURON SURVIVAL
AU1443095A (en) * 1993-12-22 1995-07-10 University Of Medicine And Dentistry Of New Jersey Novel nucleic acid sequences isolated from glial cells
US5759775A (en) * 1994-10-27 1998-06-02 Genetech, Inc. Methods for detecting nucleic acids encoding AL--1 neurotrophic factor
DE69732350T2 (de) * 1996-03-14 2005-12-22 Washington University Persephin und verwandte wachstumsfaktoren

Also Published As

Publication number Publication date
DK0787142T3 (da) 2006-05-29
US7015311B1 (en) 2006-03-21
JPH11512928A (ja) 1999-11-09
US5747655A (en) 1998-05-05
CA2194172A1 (en) 1997-03-01
CA2194172C (en) 2012-07-10
US6090778A (en) 2000-07-18
US5817622A (en) 1998-10-06
ATE315578T1 (de) 2006-02-15
EP0787142A1 (en) 1997-08-06
US5843914A (en) 1998-12-01
NZ332921A (en) 2001-03-30
JP4222629B2 (ja) 2009-02-12
AU714107B2 (en) 1999-12-16
MX9800277A (es) 1998-09-30
EP0787142A4 (en) 1999-04-07
DE69635738D1 (de) 2006-04-06
AU7105496A (en) 1997-03-19
NZ318939A (en) 1999-01-28
EP0787142B1 (en) 2006-01-11
NZ332922A (en) 1999-07-29
DE69635738T2 (de) 2006-08-31
WO1997008196A1 (en) 1997-03-06
US5739307A (en) 1998-04-14

Similar Documents

Publication Publication Date Title
IL122774A0 (en) Neurturin and related growth factors
EP0861894A4 (en) POLYPEPTIDE THAT SUPPRESSES DIFFERENTIATION
AU2681497A (en) Novel agouti-related gene
BG109433A (en) RET (RetL) Lead for Stimulating Nerve and Rat Growth
WO2000001823A3 (en) Flt3-l mutants and methods of use
Neuhaus et al. The human connexin32 gene is transcribed from two tissue-specific promoters
Luka et al. Mutations in human glycine N-methyltransferase give insights into its role in methionine metabolism
EP0886651A4 (en) PERSEPHIN AND ASSOCIATED GROWTH FACTORS
GR3034772T3 (en) Growth differentiation factor-12
IL133834A0 (en) Persephin and related growth factors
AU633896B2 (en) Method of detecting small cell carcinoma and use of acyl-peptide hydrolase and coding sequences therefor
NZ504445A (en) Nucleic acid sequences of genes of the high mobility group proteins and their use in treating tumours, vascular disorders and as a contraceptive
Chiannilkulchal et al. A primary expression map of the chromosome 15q15 region containing the recessive form of limb-girdle muscular dystrophy (LGMD2A) gene
NZ334970A (en) Human growth gene and short stature gene region using sequence derived from the SHOX gene
WO2000008157A3 (en) Human anion transporter genes atnov
EP0816504A3 (en) Platelet activating factor acetylhdrolase, and gene thereof
Falaschi et al. The three DNA polymerases of animal cells: properties and functions
RU2003123108A (ru) Мутантные формы человеческого белка fgf23, снижающие содержание фосфора в крови
AU7610396A (en) Connective tissue growth factor-3
Yamada et al. p33, an endogenous target protein for arginine‐specific ADP‐ribosyltransferase in chicken polymorphonuclear leukocytes, is highly homologous to mim‐1 protein (myb‐induced myeloid protein‐1)
WO1998031817A3 (en) Human lysosomal sialidase and therapeutic uses thereof
Sinke et al. Localization of the human phosphatidylinositol-specific phospholipase C β3 gene (PLCB3) within chromosome band 11q13
Li et al. Cloning and sequence analysis of two embryonic β-like globin cDNAs (y and z) of hamster
DK1074621T3 (da) Humant TSC403-gen
WO1999043834A3 (en) P-selectin ligand protein, including tetrameric fusion proteins

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
EXP Patent expired